NVO - Novo Nordisk A/S

NYSE - Nasdaq Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts2233
Avg. Estimate1.241.334.985.65
Low estimate1.181.274.795.28
High estimate1.291.385.256.24
Year ago EPS0.780.913.544.98
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1133
Avg. Estimate8.07B8.53B31.69B36.72B
Low estimate8.07B8.53B30.9B34.83B
High estimate8.07B8.53B33.16B40.31B
Year ago sales5.65B6.53B25.66B31.69B
Sales growth (year/est)42.70%30.60%23.50%15.80%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS0.740.90.851.24
Actual EPS0.780.910.871.26
Difference0.040.010.020.02
Surprise %5.40%1.10%2.40%1.60%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate1.241.334.985.65
7 days ago1.241.334.995.67
30 days ago1.281.355.155.6
60 days ago1.111.24.685.2
90 days ago1.061.164.524.9
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/A1N/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesNVOIndustrySector(s)S&P 500
Current qtr.59.00%N/AN/AN/A
Next qtr.46.20%N/AN/AN/A
Current year40.70%N/AN/AN/A
Next year13.50%N/AN/AN/A
Next 5 years (per annum)2.80%N/AN/AN/A
Past 5 years (per annum)12.63%N/AN/AN/A